Brinker Capital Investments, LLC Invitae Corp Transaction History

Brinker Capital Investments, LLC

  • $5.01 Billion
  • Q4 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
SELL
$14.7 - $28.67 $125,229 - $244,239
-8,519 Closed
0 $0
Q2 2021

Aug 03, 2021
BUY
$26.09 - $40.4 $3,313 - $5,130
127 Added 1.51%
8,519 $287,000
Q1 2021

May 12, 2021
SELL
$33.06 - $56.93 $264,711 - $455,838
-8,007 Reduced 48.83%
8,392 $321,000
Q4 2020

Feb 16, 2021
BUY
$39.09 - $57.4 $322,179 - $473,090
8,242 Added 101.04%
16,399 $686,000
Q3 2020

Dec 03, 2020
BUY
$28.43 - $44.67 $231,903 - $364,373
8,157 New
8,157 $354,000

Others Institutions Holding NVTA

# of Institutions
38
Shares Held
2.12M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email